Silver Book Fact

“Knowing that his disease had a high cure rate, Ben Dacus felt a sense of security at a time of great uncertainty. In 1988 he was diagnosed with Hodgkin’s disease.

Strangely enough, Ben’s reaction to his diagnosis was one of relief. ‘I was relieved to know my illness had a name, and because of the high cure rate, I never really feared that I was going to die. Hodgkin’s had a long history of research, and doctors had been treating it succesfully for many year.’

When radiation treatments didn’t work, Ben was devastated. But to his relief chemotherapy afforded him a rapid recovery.

Looking back on his illness, Ben says he is thankful for medical research. ‘It didn’t occur to me at the time I was going through treatment to consider how medical research had brought treatment methods to the point it had. But I was thankful to live in a day and age when cancer is treatable. If it had been the 1950s, I would have died four years later.”

Investment in Research Saves Lives and Money. http://www.researchamerica.org/advocacy/investment.html. Published 2005

Reference

Title
Investment in Research Saves Lives and Money
Publisher
Research!America
Publication Date
Published 2005
Authors
Research!America
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Medical research that resulted in a 1/5 reduction in deaths from cancer would be worth $10 trillion to Americans-double the national debt.  
  • From 2007 to 2011, lung cancer incidence rates decreased by three percent each year in men and 2.2 percent each year in women.  
  • “Knowing that his disease had a high cure rate, Ben Dacus felt a sense of security at a time of great uncertainty. In 1988 he was diagnosed with Hodgkin’s disease. Strangely…  
  • A prostate cancer vaccine, sipleucel-T immunotherapy, in men with metastatic castration-resistant prostate cancer, reduced the risk of death by 22 percent compared to placebo, and represented a 4.2 month improvement in…  
  • Treating cancer patients with oral medicine versus intravenous chemotherapy results in a 2/3 reduction in hospital time and a greater than 50% reduction in costly medication side effects.